People · Operator

Doug French

Named in public records as an officer, director or promoter · active 2016–2025 · Hospitals and Physicians, Biotechnology

2
Companies
3
Filings
$57.9M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Hospitalists Now, Inc.Hospitals and PhysiciansSeries B$50.9M$672.4M2016
CryOSA, Inc.BiotechnologySeries A$7.0M$19.5M2025
Operator network

Doug French at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Kevin Lalande · 8 companies · 1 sharedKevin LalandeAndreas Hildebrand · 6 companies · 1 sharedAndreas HildebrandDouglas French · 4 companies · 1 sharedDouglas FrenchEvan Melrose · 4 companies · 1 sharedEvan MelroseBarry Fromberg · 2 companies · 1 sharedBarry FrombergSteven Seach · 2 companies · 1 sharedSteven SeachFrancisco Loya · 1 companies · 1 sharedFrancisco LoyaLew Little · 1 companies · 1 sharedLew LittleMichael Gonzales · 1 companies · 1 sharedMichael GonzalesScott Klosterman · 1 companies · 1 sharedScott KlostermanJames Eadie · 6 companies · 1 sharedJames EadieDonald Gonzales · 3 companies · 1 sharedDonald GonzalesDavid Belitz · 2 companies · 1 sharedDavid BelitzLaura Stoltenberg · 1 companies · 1 sharedLaura StoltenbergHospitalists Now, Inc. · $50.9M raisedHospitalists Now, Inc.CryOSA, Inc. · $7.0M raisedCryOSA, Inc.Doug FrenchDF
Doug French Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Doug French on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Kevin Lalande18
James Eadie16
Andreas Hildebrand16
Evan Melrose14
Douglas French14
Donald Gonzales13
Steven Seach12
Barry Fromberg12
David Belitz12
Francisco Loya11
Michael Gonzales11
Laura Stoltenberg11
Scott Klosterman11
Lew Little11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.